Gerben Bouma

2.1k total citations
37 papers, 1.4k citations indexed

About

Gerben Bouma is a scholar working on Immunology, Genetics and Molecular Biology. According to data from OpenAlex, Gerben Bouma has authored 37 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Immunology, 11 papers in Genetics and 10 papers in Molecular Biology. Recurrent topics in Gerben Bouma's work include T-cell and B-cell Immunology (11 papers), Cellular Mechanics and Interactions (9 papers) and Immunotherapy and Immune Responses (9 papers). Gerben Bouma is often cited by papers focused on T-cell and B-cell Immunology (11 papers), Cellular Mechanics and Interactions (9 papers) and Immunotherapy and Immune Responses (9 papers). Gerben Bouma collaborates with scholars based in United Kingdom, United States and Netherlands. Gerben Bouma's co-authors include Adrian J. Thrasher, Siobhan O. Burns, Michael P. Blundell, Hemmo A. Drexhage, Austen Worth, Marjan A. Versnel, Luis Apolonia, Mary Collins, Annet F. Wierenga‐Wolf and Tatjana Nikolić and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Gerben Bouma

36 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerben Bouma United Kingdom 24 695 509 398 298 279 37 1.4k
Cinzia Mazza Italy 19 479 0.7× 263 0.5× 276 0.7× 262 0.9× 233 0.8× 44 1.2k
Alain Fischer France 13 653 0.9× 507 1.0× 298 0.7× 136 0.5× 206 0.7× 18 1.5k
Donn M. Stewart United States 20 468 0.7× 529 1.0× 258 0.6× 391 1.3× 525 1.9× 33 1.5k
Sau‐Ping Kwan United States 20 774 1.1× 496 1.0× 369 0.9× 357 1.2× 360 1.3× 31 1.5k
Eric J. Allenspach United States 20 1.4k 2.0× 472 0.9× 209 0.5× 329 1.1× 77 0.3× 32 2.0k
Pierre G. Lutz France 23 276 0.4× 953 1.9× 429 1.1× 178 0.6× 211 0.8× 51 1.5k
Mónica Gordón‐Alonso Spain 20 918 1.3× 790 1.6× 99 0.2× 380 1.3× 332 1.2× 24 1.9k
Fujiko Kitamura Japan 25 1.0k 1.5× 770 1.5× 136 0.3× 258 0.9× 478 1.7× 49 2.1k
Austen Worth United Kingdom 24 867 1.2× 353 0.7× 384 1.0× 227 0.8× 264 0.9× 56 1.8k
Marc‐André Wurbel United States 18 1.9k 2.7× 567 1.1× 208 0.5× 156 0.5× 139 0.5× 22 2.4k

Countries citing papers authored by Gerben Bouma

Since Specialization
Citations

This map shows the geographic impact of Gerben Bouma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerben Bouma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerben Bouma more than expected).

Fields of papers citing papers by Gerben Bouma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerben Bouma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerben Bouma. The network helps show where Gerben Bouma may publish in the future.

Co-authorship network of co-authors of Gerben Bouma

This figure shows the co-authorship network connecting the top 25 collaborators of Gerben Bouma. A scholar is included among the top collaborators of Gerben Bouma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerben Bouma. Gerben Bouma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
D’Haens, Geert, Laurent Peyrin‐Biroulet, Daniel JB Marks, et al.. (2023). A randomised, double‐blind, placebo‐controlled study of the LAG‐3‐depleting monoclonal antibody GSK2831781 in patients with active ulcerative colitis. Alimentary Pharmacology & Therapeutics. 58(3). 283–296. 6 indexed citations
2.
Bouma, Gerben, Michael Herdman, Michael Byrne, et al.. (2021). Structure and Functional Characterization of a Humanized Anti-CCL20 Antibody following Exposure to Serum Reveals the Formation of Immune Complex That Leads to Toxicity. The Journal of Immunology. 206(5). 1067–1076. 3 indexed citations
3.
Laffan, Susan, Cindy Fishman, Kiran Nistala, et al.. (2020). Immune complex disease in a chronic monkey study with a humanised, therapeutic antibody against CCL20 is associated with complement-containing drug aggregates. PLoS ONE. 15(4). e0231655–e0231655. 9 indexed citations
4.
Poel, Cees E. van der, Goran Bajic, Charles Macaulay, et al.. (2019). Follicular Dendritic Cells Modulate Germinal Center B Cell Diversity through FcγRIIB. Cell Reports. 29(9). 2745–2755.e4. 33 indexed citations
5.
Lee, Pamela, Damián Lobato‐Márquez, Andrea Sirianni, et al.. (2017). Wiskott-Aldrich syndrome protein regulates autophagy and inflammasome activity in innate immune cells. Nature Communications. 8(1). 1576–1576. 44 indexed citations
6.
Baptista, Marisa A. P., Márton Keszei, Mariana M.S. Oliveira, et al.. (2016). Deletion of Wiskott–Aldrich syndrome protein triggers Rac2 activity and increased cross-presentation by dendritic cells. Nature Communications. 7(1). 12175–12175. 27 indexed citations
7.
Malinova, Dessislava, Marco Fritzsche, Carla R. Nowosad, et al.. (2015). WASp-dependent actin cytoskeleton stability at the dendritic cell immunological synapse is required for extensive, functional T cell contacts. Journal of Leukocyte Biology. 99(5). 699–710. 47 indexed citations
8.
Bouma, Gerben, Natalie A. Carter, Mike Recher, et al.. (2014). Exacerbated experimental arthritis in Wiskott–Aldrich syndrome protein deficiency: Modulatory role of regulatory B cells. European Journal of Immunology. 44(9). 2692–2702. 21 indexed citations
9.
Lang, Philipp A., Namir Shaabani, Nadine Honke, et al.. (2012). Reduced type I interferon production by dendritic cells and weakened antiviral immunity in patients with Wiskott-Aldrich syndrome protein deficiency. Journal of Allergy and Clinical Immunology. 131(3). 815–824.e2. 17 indexed citations
10.
Bouma, Gerben, Ariadna Mendoza‐Naranjo, Michael P. Blundell, et al.. (2011). Cytoskeletal remodeling mediated by WASp in dendritic cells is necessary for normal immune synapse formation and T-cell priming. Blood. 118(9). 2492–2501. 57 indexed citations
11.
Bouma, Gerben, Phil Ancliff, Adrian J. Thrasher, & Siobhan O. Burns. (2010). Recent advances in the understanding of genetic defects of neutrophil number and function. British Journal of Haematology. 151(4). 312–326. 39 indexed citations
12.
Nibali, Luigi, Gerben Bouma, M. Parkar, et al.. (2010). Genetic Variants Associated With Neutrophil Function in Aggressive Periodontitis and Healthy Controls. Journal of Periodontology. 81(4). 527–534. 11 indexed citations
13.
Blundell, Michael P., Gerben Bouma, Austen Worth, et al.. (2009). Phosphorylation of WASp is a key regulator of activity and stability in vivo. Proceedings of the National Academy of Sciences. 106(37). 15738–15743. 48 indexed citations
14.
Himoudi, Nourredine, Mengyong Yan, Gerben Bouma, et al.. (2009). Migratory and Antigen Presentation Functions of IFN-Producing Killer Dendritic Cells. Cancer Research. 69(16). 6598–6606. 11 indexed citations
15.
Bouma, Gerben, Siobhan O. Burns, & Adrian J. Thrasher. (2009). Wiskott–Aldrich Syndrome: Immunodeficiency resulting from defective cell migration and impaired immunostimulatory activation. Immunobiology. 214(9-10). 778–790. 68 indexed citations
16.
Blundell, Michael P., Gerben Bouma, Yolanda Calle, et al.. (2008). Improvement of Migratory Defects in a Murine Model of Wiskott–Aldrich Syndrome Gene Therapy. Molecular Therapy. 16(5). 836–844. 31 indexed citations
17.
Apolonia, Luis, Simon N. Waddington, Natalie J Ward, et al.. (2007). Stable Gene Transfer to Muscle Using Non-integrating Lentiviral Vectors. Molecular Therapy. 15(11). 1947–1954. 134 indexed citations
18.
Boven, Leonie A., Farshid Noorbakhsh, Gerben Bouma, et al.. (2007). Brain-derived human immunodeficiency virus-1 Tat exerts differential effects on LTR transactivation and neuroimmune activation. Journal of NeuroVirology. 13(2). 173–184. 22 indexed citations
19.
Olivier, Aurélie, Laurence Jeanson-Leh, Gerben Bouma, et al.. (2005). A Partial Down-regulation of WASP Is Sufficient to Inhibit Podosome Formation in Dendritic Cells. Molecular Therapy. 13(4). 729–737. 39 indexed citations
20.
Bouma, Gerben, Tatjana Nikolić, Cornelia G van Helden-Meeuwsen, et al.. (2004). NOD mice have a severly impaired ability to recruit leukocytes into sites of inflammation. European Journal of Immunology. 35(1). 225–235. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cinzia Mazza Breakdown of academic impact, for papers by Alain Fischer Breakdown of academic impact, for papers by Donn M. Stewart Breakdown of academic impact, for papers by Sau‐Ping Kwan Breakdown of academic impact, for papers by Eric J. Allenspach Breakdown of academic impact, for papers by Pierre G. Lutz Breakdown of academic impact, for papers by Mónica Gordón‐Alonso Breakdown of academic impact, for papers by Fujiko Kitamura Breakdown of academic impact, for papers by Austen Worth Breakdown of academic impact, for papers by Marc‐André Wurbel
Rankless by CCL
2026